Home

Kwality Pharmaceuticals Ltd PE Ratio

Image

Kwality Pharmaceuticals Ltd

NSE: KWALITYPHARMA

PE

20.7

Last updated on: Feb 22, 2025

Key Highlights

  • The P/E Ratio of Kwality Pharmaceuticals Ltd is 20.7 as of 22 Feb 15:30 PM .
  • The P/E Ratio of Kwality Pharmaceuticals Ltd changed from 3.2 on March 2020 to 17.9 on March 2024 . This represents a CAGR of 41.10% over 5 years.
  • The Latest Trading Price of Kwality Pharmaceuticals Ltd is ₹ 701.05 as of 21 Feb 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Kwality Pharmaceuticals Ltd

No data available

Company Fundamentals for Kwality Pharmaceuticals Ltd

Image

Kwality Pharmaceuticals Ltd

NSE: KWALITYPHARMA

Share Price

₹ 701.05

-9.80 (-1.38%)

stock direction

Last updated on: Feb 21, 2025

Market Price of Kwality Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Kwality Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 2025701.05
20 Feb 2025710.85
19 Feb 2025696.2
18 Feb 2025700.8
17 Feb 2025708.2
14 Feb 2025755.45
13 Feb 2025783.6
12 Feb 2025777.95
11 Feb 2025702
10 Feb 2025767.85

SWOT Analysis Of Kwality Pharmaceuticals Ltd

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Kwality Pharmaceuticals Ltd

Asset Value vs Market Value of Kwality Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Kwality Pharmaceuticals Ltd727.42
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

PE Ratio of Kwality Pharmaceuticals Ltd Explained

727.42

Market cap

29

Earnings

20.7X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Kwality Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Kwality Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Kwality Pharmaceuticals Ltd

No data available

* All values are in %

About Kwality Pharmaceuticals Ltd

  • Kwality Pharmaceuticals Limited was Incorporated on May 4th 1983 when its founder Mr. Ramesh Arora was inspired to begin his own venture leaving behind the already flourishing family business of spinning and aromatics.
  • With little background of finished pharmaceuticals and high held spirits and will, he started this business.
  • He received his first drug license in 1981 approved for liquid oral manufacturing.
  • Presently, the Company has 48 different sections available at their production centres. Kwality Pharmaceuticals Ltd. are manufacturer of finished pharmaceutical formulations in a Liquid Orals, Dry Syrups, Tablets, Capsules, Sterile Powder for Injections and small volume injectables.
  • The Company has the most modern & sophisticated Plant, Equipment, technique, and workforce.

Kwality Pharmaceuticals Ltd News Hub

Kwality Pharmaceuticals consolidated net profit rises 54.24% in the June 2024 quarter

Net profit of Kwality Pharmaceuticals rose 54.24% to Rs 8.36 crore in the quarter ended June 2024 as

Read more

12 Aug 24

Kwality Pharmaceuticals to discuss results

Kwality Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 August 20

Read more

06 Aug 24

Kwality Pharmaceuticals schedules AGM

Kwality Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held

Read more

10 Sept 24

Kwality Pharmaceuticals to conduct AGM

Kwality Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held

Read more

10 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Kwality Pharmaceuticals Ltd

What is the current PE Ratio of Kwality Pharmaceuticals Ltd?

The Current PE Ratio of Kwality Pharmaceuticals Ltd is 20.74 as on 22 Feb 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 22 Feb 2025.

What was the PE Ratio of Kwality Pharmaceuticals Ltd last year?

The PE Ratio of Kwality Pharmaceuticals Ltd was 16.47 last year, now the PE ratio is 20.74, showing a year-on-year growth of 25.9%.

What does the PE Ratio of Kwality Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Kwality Pharmaceuticals Ltd is 20.74. This ratio indicates that investors are willing to pay 20.74 times the earnings per share for each share of Kwality Pharmaceuticals Ltd.

What is the PE Ratio Growth of Kwality Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Kwality Pharmaceuticals Ltd grew by 25.9% whereas, the EPS ratio grew by 0.7.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions